SBFM Earnings Sunshine Biopharma Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–12 of 12
| Q3 2025 | 2025-09-30 | -0.98 | 2025-11-13 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.82 | 2025-08-12 | 10-Q |
| Q1 2025 | 2025-03-31 | -0.44 | 2025-05-15 | 10-Q |
| FY 2024 | 2024-12-31 | -7.32 | 2025-04-01 | 10-K |
| Q3 2025 | 2024-09-30 | -13.61 | 2025-11-13 | 10-Q |
| Q2 2025 | 2024-06-30 | -43.48 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -2.00 | 2025-05-15 | 10-Q |
| FY 2024 | 2023-12-31 | -351.36 | 2025-04-01 | 10-K |
| Q1 2024 | 2023-03-31 | -7.73 | 2024-05-20 | 10-Q |
| FY 2023 | 2022-12-31 | -1.76 | 2024-03-28 | 10-K |
| Q1 2023 | 2022-03-31 | -0.23 | 2023-05-10 | 10-Q |
| FY 2022 | 2021-12-31 | -4.76 | 2023-04-04 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.